Skip to content

Prevalence of Suicidal Risk in Psychiatric Settings

Prevalence of Suicidal Risk in Psychiatric Settings

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07746193
Acronym
RSCP
Enrollment
262
Registered
2026-08-04
Start date
2025-05-01
Completion date
2025-06-30
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychiatric Disorder, Suicidal Crisis

Keywords

Suicidal Crisis

Brief summary

France is among the countries with one of the highest suicide rates in the world, far ahead of its neighboring nations \[Wasserman et al., 2012\]. Suicide represents the second leading cause of death among 15-24-year-olds, just after road accidents, and the leading cause of death among 25-34-year-olds. In this context, a better utilization of all components of the healthcare system seems highly desirable, particularly through greater involvement of community psychiatrists in suicide prevention strategies. Approximately 25% of individuals who die by suicide have consulted a psychiatrist in the month preceding their death \[Luoma et al., 2002\], yet few data are available on this topic, especially regarding consultations with community psychiatrists outside of hospital settings. Study objectives Main objective To assess the prevalence of suicidal risk during the 15 days preceding an outpatient psychiatric consultation in the Clermont-Ferrand area. Main secondary objectives * To describe the recruited population and potentially associated factors (age, sex, etc.). * To assess the psychological pain of these individuals over the same period when suicidal thoughts are strongest, or, if absent, when they feel at their worst. * To assess the self-esteem of these individuals over the same period when suicidal thoughts are strongest, or, if absent, when they feel at their worst.

Interventions

None listed

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any adult patient consulting at the psychiatrist's office during the recruitment period (regardless of the reason for consultation) and who has provided consent to participate in this study.

Exclusion criteria

* Minor patient or refusal to participate in the study. * Patient who has already completed the self-questionnaires previously (e.g., second consultation within the same week). * Patient unable to understand or complete the self-questionnaires (due to cognitive impairment or insufficient understanding of the French language).

Design outcomes

Primary

MeasureTime frameDescription
score at scale a risk suicidal of Ducher (aRSD)Day 1aRSD scale score from 0 to 10 (worse is 10)

Secondary

MeasureTime frameDescription
SESTDay 1Self-Esteem Scale (SES) score. From 0 to 24. 24 is the worste outcome
VASTDay 1Visual Analog Scale (VAS) score for psychological pain. from 0 to 10. 10 is the worse outcome.

Countries

France

Contacts

STUDY_CHAIRPierre-Michel Llorca

CHU de Clermont-Fd

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026